SC
OGN icon

SummitTX Capital’s Organon & Co OGN Stock Holding History

SummitTX Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,455
Closed -$140K – 951
2026
Q1 		$140K Buy
+23,455
New +$176K ﹤0.01% 705
2025
Q3 		– Sell
-60,079
Closed -$582K – 917
2025
Q2 		$582K Sell
60,079
-18,333
-23% -$189K 0.03% 482
2025
Q1 		$1.17M Buy
+78,412
New +$1.21M 0.05% 370

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

SummitTX Capital's OGN Position: Q2 2026 in Review

SummitTX Capital sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 23,455 shares — an estimated $140K sold.

SummitTX Capital first reported a position in OGN in Q1 2025 and held it in 3 quarters. The position peaked at $1.17M in Q1 2025. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • SummitTX Capital reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • SummitTX Capital sold 23,455 Organon & Co shares in Q2 2026, an estimated $140K.
  • SummitTX Capital first reported a position in Organon & Co in Q1 2025 and held it in 3 quarters.
  • SummitTX Capital's Organon & Co position peaked at $1.17M in Q1 2025.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.